A carregar...

Clinical Development of PD-1 Blockade in Hematologic Malignancies

Clinical development of Immune checkpoint inhibitors targeting the programmed cell death 1 (PD-1) pathway has led to clinical benefits for patients with multiple solid tumor and hematologic malignancies and has revolutionized modern oncology. High response rates to PD-1 blockade in patients with cla...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer J
Main Authors: Pianko, Matthew J., Goldberg, Aaron D., Lesokhin, Alexander M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5785103/
https://ncbi.nlm.nih.gov/pubmed/29360725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!